Teva and Takeda enter into new venture for generics in Japan
Teva Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Co. Ltd. entered into a new partnership in Japan. The new venture will begin in Q2 2016 with Teva owning 51% and Takeda 49%. The partnership will operate as an independent company with its own board and management team. Further details have not yet been disclosed.
- Generic Drugs
- OTC, Consumer
- Joint Venture
- Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com